This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.3390/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q93262517
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 23 квітня 2020 wetenschappelijk artikel scientific article published on 23 April 2020 artículu científicu espublizáu n'abril de 2020 im April 2020 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2020
p:P577
wds:Q93262517-306810CC-95CA-4BD5-B30A-3841CA05B1F5
wdt:P577
2020-04-23T00:00:00Z
rdfs:label
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
skos:prefLabel
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
schema:name
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
p:P50
wds:Q93262517-DB3D7140-E71A-452C-ABF0-A8C7ED1C55E1 wds:Q93262517-CA74CC61-34AF-4A3F-937C-6A5D31DA678E wds:Q93262517-D94AC8E7-8E4D-4D31-8B72-BB3F42C4D21A wds:Q93262517-35658996-0271-4650-9EA4-ED4DF69B84F4 wds:Q93262517-0316C77C-22FA-42A2-9BA3-B25271167CEB wds:Q93262517-351EC292-78FB-4A09-83B5-C5D586BDFADB
wdt:P50
wd:Q92771429 wd:Q3437917 wd:Q6255800 wd:Q91273671 wd:Q37388229 wd:Q91273666
p:P1476
wds:Q93262517-4DCAD532-79D0-445A-B295-DB11CD9C9C00
wdt:P1476
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
p:P31
wds:Q93262517-4C1AA713-3304-4B03-9331-06977B344AF6
wdt:P31
wd:Q13442814
p:P698
wds:Q93262517-252C4760-6282-4FC6-8A03-C8DA68CDDE79
wdtn:P698
n9:32340100
wdt:P698
32340100
p:P1433
wds:Q93262517-C25FF803-9486-40F0-A608-FEC46707065E
wdt:P1433
wd:Q23929963
p:P433
wds:Q93262517-4314B3BD-96C8-4D97-9315-CC3BD358B858
p:P478
wds:Q93262517-5F820882-3F9F-423E-B979-F42993AB1AE0
wdt:P433
4
wdt:P478
10
p:P356
wds:Q93262517-77B41887-F879-4820-BC48-C17DD1D7D8FA
wdtn:P356
n10:BIOM10040649
wdt:P356
10.3390/BIOM10040649
p:P275
wds:Q93262517-484d7061-05f6-41a1-af23-bccf01e7488a
p:P6216
wds:Q93262517-91691909-7a41-49f4-96ac-1463dedaabb8
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q93262517-88B3D22F-F44F-4BFB-B5EC-D51F23121EDF
wdt:P932
7226584